Many youth in foster care are diagnosed with disruptive behavior disorder (DBD), a diagnosis indicative of aggression and behavior problems. These youth, who are at high risk for being placed in psychiatric residential treatment facilities (PRTF), are commonly prescribed antipsychotic (AP) medications off-label. However, treating children in the community is an important goal, and although AP medications can have severe side effects, these prescriptions may help to achieve this goal. In this study, we used Medicaid data to determine whether AP medications reduce the risk of admission to PRTF among two groups of children with DBD: those with DBD only and those who were diagnosed with DBD in addition to at least one of two conditions indicated for AP prescribing (psychosis and bipolar disorder.) Event history models show that AP medications are associated with a high rate of admission, which are likely due to the higher mental and behavioral health needs of youth who are prescribed. However, youth diagnosed with both DBD and indications who are prescribed an AP medication have one-tenth the rate of admission of similar youth who are not prescribed. For youth with DBD only, the findings are inconclusive. Given these mixed results, practitioners should follow clinical guidelines; ensuring youth are treated with psychosocial interventions and other psychotropic medications prior to AP prescribing. Agencies should attempt to address systemic factors such as shortages of foster homes, increased availability of therapeutic foster care, and implementation of in-home prevention services.
Public Policy Relevance StatementThis study suggests that some youth in foster care diagnosed with disruptive behavior disorder may benefit from antipsychotic medications, helping to keep them in the community and out of psychiatric residential treatment. In the context of the health risks associated with these medications in youth, however, these youth should be provided appropriate psychosocial and preventive treatments. aaa Y outh in foster care have high rates of behavioral disorder diagnoses, including disruptive behavior disorders (DBD), relative to youth not in foster care. If untreated, many youth with DBDs may require care in settings such as psychiatric residential treatment facilities (PRTFs), a restrictive and medically supervised form of residential placement for youth under 21. Although medical necessity is a prerequisite for admission, experiences with child protective services and out-of-home placements independently predict admission: most CPS investigations do not result in removal; some youth placed in foster care come from the juvenile justice system or voluntary placement; and both of these characteristics may proxy for other unobserved characteristics (Lanier & Rose, 2017). Further, a systematic review argues that PRTF placements are a costly residential setting (more than $55,000 per year per resident) in which This document is copyrighted by the American Psychological Association or one of its allied publishers.This...